The Patent Finder

Dabur India Limited

Also on record
Records under this name other than patents Dabur India Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Dabur India Limited

PatentTitleStatus Expires Confidence
US 6,838,569Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
Formerly held
Term ended
Term ended Apr 22, 2023 · From the USPTO record
Term endedTerm ended Apr 22, 2023From the USPTO record
US D574,710Hair cream container
Term ended
Term ended Aug 12, 2022 · From the USPTO record
Term endedTerm ended Aug 12, 2022From the USPTO record
US 6,900,342Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
Formerly held
Lapsed on the fee record
Ended May 31, 2017 · From the USPTO record
Lapsed on the fee recordEnded May 31, 2017From the USPTO record
US 7,247,738Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
Formerly held
Lapsed on the fee record
Ended Jul 24, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jul 24, 2015From the USPTO record
US 6,506,905Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid
Formerly held
Lapsed on the fee record
Ended Jan 14, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jan 14, 2015From the USPTO record
US 7,759,494Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl)ethoxy-carbonyl]-5-oxazolidine carboxylic acids
Formerly held
Lapsed on the fee record
Ended Jul 20, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jul 20, 2014From the USPTO record
US 6,891,050Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
Formerly held
Lapsed on the fee record
Ended May 10, 2013 · From the USPTO record
Lapsed on the fee recordEnded May 10, 2013From the USPTO record
US 6,881,852Process of purification of paclitaxel and docetaxel
Formerly held
Lapsed on the fee record
Ended Apr 19, 2013 · From the USPTO record
Lapsed on the fee recordEnded Apr 19, 2013From the USPTO record
US 6,599,541Composition for treatment of drug resistant bacterial infections and a method of treating drug resistant bacterial infections
Lapsed on the fee record
Ended Jul 29, 2011 · From the USPTO record
Lapsed on the fee recordEnded Jul 29, 2011From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited